⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TEVA News
Teva Pharmaceutical Industries Limited American Depositary Shares
Teva Closes Acquisition of Emalex Biosciences, Strengthening Late-Stage Neuroscience Pipeline and Advancing Pivot to Growth Strategy
globenewswire.com
TEVA
Questex’s Fierce Life Sciences Announces the 2026 Partnerships with Sites Summit Agenda
globenewswire.com
LLY
BIIB
AZN
BMY
MRK
TEVA
Alvotech announces FDA acceptance of Biologics License Application for AVT16, a proposed interchangeable biosimilar to Entyvio®
globenewswire.com
ALVO
TEVA
Alvotech announces resubmission of U.S. Biologics License Applications for AVT05, a proposed biosimilar to Simponi® and Simponi Aria®, and AVT06, a proposed biosimilar to Eylea®
globenewswire.com
ALVO
TEVA
Alvotech announces resubmission of U.S. Biologics License Applications for AVT05, a proposed biosimilar to Simponi® and Simponi Aria®, and AVT06, a proposed biosimilar to Eylea®
globenewswire.com
ALVO
TEVA
Teva to Present at the Goldman Sachs Global Healthcare Conference
globenewswire.com
TEVA
Form 8-K
sec.gov
TEVA
TEVJF
Interact Enters a New Era of Growth with Brand Evolution, AI Innovation, and Industry Recognition
globenewswire.com
LEVI
DPZ
TEVA
Medincell to Participate in Jefferies and Evercore Investor Conferences in the U.S. in June
businesswire.com
TEVA
CGRP Inhibitors Market to Reach US$12.5 Bn by 2033 Expands with Rising Migraine Awareness and Advanced Targeted Therapies - Persistence Market Research
prnewswire.com
AMGN
LLY
TEVA
PFE
ABBV